nuroflux
- Company typePrivate
- Founded2021
- HeadquartersSydney, Australia
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
nuroflux firmographics
Firmographics- Name
- nuroflux
- Website
- https://nuroflux.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
nuroflux industry classification
Industry- Product category
- Neurological Monitoring Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)
- akta.pro secondary industries
- Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK)
Keywords
Where nuroflux is headquartered
LocationHeadquarters
- HQ city
- Sydney
- HQ country
- Australia
- HQ region
- Oceania
Markets served
nuroflux business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
nuroflux product offering
Product offeringCore offering
Nuroflux develops the nuroflux™ wearable, a proprietary multi-modal device that non-invasively monitors brain activity via electroencephalography (EEG) and brain blood flow via a novel electrocardiography-based metric. The device is designed to provide continuous, real-time monitoring of stroke patients to detect secondary strokes and monitor treatment effectiveness between CT perfusion scans, with future potential for pre-hospital and self-administered remote monitoring.
Product overview
Nuroflux offers a single unified wearable product called nuroflux™ — the world's first wearable for non-invasive continuous monitoring of brain activity and brain blood flow. The device uses a proprietary multi-modal system combining EEG and a novel ECG-based metric to provide simultaneous monitoring. It is designed for stroke patients in clinical settings, pre-hospital environments, and remote home monitoring by high-risk patients. Multiple modalities enable rich datasets for deep-learning analysis and predictive models.
Differentiator
Problem solved
Functional benefit
Products and services
- nuroflux™ Wearable Monitoring System
Quantifiable outcome
- Current standard care detects neurological deterioration in only 45% of positive cases
- +1 more outcomes
Companies that use nuroflux
Customer profileSegments4 records
Ideal customer profiles3 records
nuroflux technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature4 records
nuroflux partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- The George Institute for Global HealthcoreStrategic partnership with The George Institute for Global Health, a leading not-for-profit medical research institute focused on solving major global health challenges including stroke. The collaboration aims to revolutionise stroke patient care and improve outcomes, especially in underserved communities. The institute provides clinical support including neurologist Professor Craig Anderson (President-elect of World Stroke Organisation) and Associate Professor Candice Delcourt.
- UNSW FoundersminorCollaborating institution providing startup and entrepreneurship support through UNSW Founders program.
- RemarkableminorCollaborating institution - Remarkable accelerator program supporting startups in the health technology space.
Scale indicators4 records
Recent moves5 records
Expansion highlights5 records
nuroflux competitors and assessment
Company assessmentBroad incumbents
- Edwards Lifesciences: Markets FORE-SIGHT cerebral oximetry technology for non-invasive brain oxygen saturation monitoring in surgical and ICU settings. Competes on the brain blood flow monitoring dimension of nuroflux's multi-modal wearable.
- Masimo: Established patient monitoring incumbent with FDA-cleared SedLine EEG-based brain function monitor and O3 regional oximetry for cerebral oxygenation. Competes for the same hospital brain-monitoring budget as nuroflux, but operates across a much broader vital signs portfolio.
- Medtronic: Sells INVOS cerebral/somatic oximetry and BIS brain monitoring systems widely used in operating rooms and ICUs. Direct overlap with nuroflux's continuous brain blood flow and EEG monitoring use cases in hospital settings.
Direct peers
- Compumedics: Australia-based manufacturer of clinical and research EEG, sleep, and brain monitoring systems. Direct peer in neurological EEG wearables, with comparable product category, customer base (hospitals/research), and origin in the Australian medtech ecosystem.
Emerging players
- Ceribell: Developer of a portable, point-of-care EEG system for rapid brain monitoring in hospitals and emergency settings. Closely comparable to nuroflux in targeting continuous, accessible EEG-based neurological monitoring outside traditional EEG labs.
- BrainScope: Developer of EEG-based, non-invasive handheld devices for traumatic brain injury assessment. Comparable to nuroflux's TBI indication and its approach of using EEG-derived signals for objective brain injury evaluation outside imaging.
- NovaSignal: Pursues non-invasive, real-time cerebral blood flow assessment using robotic ultrasound. Comparable to nuroflux on the brain blood flow monitoring axis, though using a different sensing modality.
- Nonin Medical: Specialist in non-invasive cerebral and tissue oximetry sensors for clinical and remote monitoring. Overlaps with nuroflux on the non-invasive brain blood flow monitoring use case.
- iSchemaView (RAPID): Provides AI-enhanced CT perfusion and MRI imaging software widely used in acute stroke workflows. Adjacent competitor addressing the same stroke monitoring/decision gap, though based on imaging rather than wearable electrophysiology.
- NIRx Medizintechnik: Supplies fNIRS-based neuroimaging systems for non-invasive brain activity and hemodynamics monitoring in clinical and research settings. Comparable to nuroflux's multi-modal non-invasive brain monitoring approach.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
nuroflux financial estimates
Financial estimateRevenue estimate
Valuation estimate
nuroflux leadership team
Management profileNumber of profiles
Profiles11 records
nuroflux funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
nuroflux M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about nuroflux
What does nuroflux do?
Nuroflux develops the nuroflux™ wearable, a proprietary multi-modal device that non-invasively monitors brain activity via electroencephalography (EEG) and brain blood flow via a novel electrocardiography-based metric. The device is designed to provide continuous, real-time monitoring of stroke patients to detect secondary strokes and monitor treatment effectiveness between CT perfusion scans, with future potential for pre-hospital and self-administered remote monitoring.
Is nuroflux a public or private company?
nuroflux is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was nuroflux founded?
nuroflux was founded in 2021. It employs 1 to 10 people.
Where is nuroflux based?
nuroflux is headquartered in Sydney, Australia, in the Oceania region.
Who are nuroflux's main competitors?
Broad incumbents on record are Edwards Lifesciences, Masimo and Medtronic. Compumedics is listed as a direct peer. Emerging players are Ceribell, BrainScope, NovaSignal, Nonin Medical, iSchemaView (RAPID) and NIRx Medizintechnik.
Does nuroflux have an API?
No public API is recorded for nuroflux.
What industry is nuroflux in?
nuroflux's product category is Neurological Monitoring Medical Devices. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3845.